Home/Pipeline/Pediatric Indications (<2 years)

Pediatric Indications (<2 years)

Type 1 Diabetes

ResearchExploratory

Key Facts

Indication

Type 1 Diabetes

Phase

Research

Status

Exploratory

Company

Tandem Diabetes

About Tandem Diabetes

Tandem Diabetes Care has established itself as a formidable innovator in the diabetes technology sector by pioneering a 'software-first' approach to insulin pump design. Its core strategy revolves around its interoperable t:slim X2 and Tandem Mobi hardware platforms, enhanced by the predictive Control-IQ+ algorithm, creating a sticky ecosystem for users. The company's mission is to leverage smart technology and deep user empathy to create new possibilities and improve the lives of people with diabetes, their loved ones, and healthcare providers.

View full company profile

Therapeutic Areas

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Other Type 1 Diabetes Drugs

Drug	Company	Phase	Status
eRapa	Biodexa Pharmaceuticals	Preclinical	Research
ImmCelz™	Creative Medical Technology Holdings	Clinical Trial	Active
Adimune (ADi-001/002)	Aditxt	Preclinical / Early Clinical	Active
BioChaperone® Lispro (THDB0206)	Adocia	Phase 3	Active
AdoShell® Islet Cell Therapy	Adocia	Preclinical	Platform Development
Icovamenib (BMF-219)	Biomea Fusion	Phase 2	Completed Follow-up, Data Pending
Undisclosed Novel Strategy	CG Scientific	Pre-clinical	Early Research
Sotagliflozin	Lexicon Pharmaceuticals	Phase 3	Regulatory Path Uncertain
Stem Cell-Derived Beta Cells	BioTalentum	Pre-clinical	Active
NICHE	Continuity Biosciences	Pre-clinical	Active
Type I Diabetes	Genclis	Discovery	Active
Inreda AP®	Inreda Diabetic	Commercial	Active